What price a cure?

What price a cure?

The number of hugely expensive drugs to treat rare diseases is increasing but can we afford them?

Martin Shkreli recently gained widespread opprobrium when his company raised the price of Daraprim, a 62-year-old old drug used to treat Aids patients, by 5,000 per cent to more than $750 a pill.

The pricing strategy by Shkreli’s Turing Pharmaceuticals infuriated the public. Suddenly, pharmaceutical pricing entered the presidential debate in the US.

Billionaire Donald Trump, the Republican presidential frontrunner, called Shkreli a “spoiled brat”, while Democratic frontrunner Hillary Clinton tweeted about it as a choice...

Subscribe from just 1€

Exclusive offers

Choose the subscription that is right for you

Monthly Subscription

€1

For the first month

€19.99 Monthly Thereafter

Subscribe today

Cancel anytime

Annual Subscription

€200€149

For the first year

€199.99 annually thereafter

Subscribe today

Cancel anytime

Quarterly Subscription

€55€42

For the first 90 days

€55.00 quarterly Thereafter

Subscribe today

Cancel anytime

These offers are not available for current subscribers. Offers and pricing are subject to change without notice.

Terms & Conditions Apply

Please Subscribe or Log in to continue

Subscribe Login

Related Articles

More from The Business Post